INmune Bio to present at RBC Capital Markets Global Healthcare Conference on May 20-21

Inmune Bio, Inc.

Fireside chat and 1-on-1 virtual meetings on May 20-21, 2025, at InterContinental Barclay NY.
Presentation at 11:00am EDT; no material financial or pipeline updates announced.
Clinical-stage biotech targeting innate immune system with three product platforms.
No new clinical data, partnerships, or financial disclosures in the release.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.